Home › Funds › HOMESTEAD ADVISERS CORP › BSX

HOMESTEAD ADVISERS CORP position in BSX

BOSTON SCIENTIFIC CORP · Health Care

HOMESTEAD ADVISERS CORP reported holding 885,962 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$38.7M, representing 0.98% of its reported portfolio and ranking #41 among its reported holdings. HOMESTEAD ADVISERS CORP has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)885.96K sh
Reported value held$38.70M
Portfolio Weight0.98%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HOMESTEAD ADVISERS CORP's BSX position evolved

HOMESTEAD ADVISERS CORP first disclosed a stake in BSX in Q3 2023 at 1,640,626 shares (US$86.6M). The position peaked in Q1 2024 at 1,578,926 shares, worth US$108.2M. Across 13 filings, HOMESTEAD ADVISERS CORP increased the stake 3 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 885,962 shares valued at US$38.7M — an increase of 333,900 shares quarter over quarter.. Notable position changes include a 72% increase in Q1 2026 (shares fell 32% over the following quarter), a 41% trim in Q2 2026 (shares rose 2% over the following quarter), a 60% increase in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.64M $86.63M New
Q4 2023 1.64M $95.01M Hold
Q1 2024 1.58M $108.18M Reduce
Q2 2024 1.34M $103.08M Reduce
Q3 2024 1.14M $95.18M Reduce
Q4 2024 1.18M $105.36M Add
Q1 2025 982.53K $99.12M Reduce
Q2 2025 759.43K $81.57M Reduce
Q3 2025 668.43K $65.26M Reduce
Q4 2025 547.06K $52.16M Reduce
Q1 2026 942.06K $59.14M Add
Q2 2026 552.06K $23.56M Reduce
Q3 2026 885.96K $38.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has HOMESTEAD ADVISERS CORP held BSX?

HOMESTEAD ADVISERS CORP has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HOMESTEAD ADVISERS CORP's current position in BSX?

As of Q3 2026, HOMESTEAD ADVISERS CORP holds 885.96K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $38.70M, representing 0.98% of its reported portfolio and ranking #41.

Has HOMESTEAD ADVISERS CORP been buying or selling BSX?

In the latest 13F filing (Q3 2026), HOMESTEAD ADVISERS CORP increased its position in BSX. The position peaked in Q1 2024 at 1.58M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.